Insider Trading › LCTX › Insiders

Lineage Cell Therapeutics, Inc.

LCTX·NYSE·United States United States·Insider activity
$0.94
+0.01 (+1.13%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
LCTX
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
LCTXS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

No open-market insider purchases or sales of LCTX were filed in the last 180 days. Newest filing Mar 12, 2026 (6 months ago).

Net Insider Buying by Quarter

Shares bought (+) or sold (−) on the open market by LCTX insiders · Form 4 · last two years
-20.0K-10.0K010.0K20.0K2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 15.0K2026 Q12026 Q2: 02026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

On Record

$0Purchases · 180 days
$0Sales · 180 days
39Open-market transactions on record
0Insiders filing · 180 days

Purchases (code P) and sales (code S) of LCTX common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).

Insider Transactions

39 on record · newest trade first
AllPurchasesSalesOfficers & directors
InsiderTypeSharesPriceValueHeld afterTradedFiled
Culley Brian MPresident and CEO · Director Purchase +15.0K $1.63 $24K255.5Kdirect Mar 12, 2026Mar 12, 2026 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +0 $0.00 $049.6Mindirect Jan 27, 2025Jan 28, 2025 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +7.9M n/c —49.6Mdirect Jan 27, 2025Jan 28, 2025 Form 4 ↗
Howe Jill AnnChief Financial Officer Purchase +15.0K $0.59 $9K25.5Kdirect Nov 26, 2024Nov 26, 2024 Form 4 ↗
Samuel George A. IIIGeneral Counsel Purchase +15.0K $0.60 $9K22.2Kdirect Nov 26, 2024Nov 26, 2024 Form 4 ↗
Mulroy Michael H.Director Purchase +40.0K $0.57 $23K298.6Kdirect Nov 22, 2024Nov 25, 2024 Form 4 ↗
Culley Brian MPresident and CEO · Director Purchase +40.0K $0.60 $24K194.8Kdirect Nov 21, 2024Nov 22, 2024 Form 4 ↗
Howe Jill AnnChief Financial Officer Purchase +10.5K $0.89 $9K10.5Kdirect Aug 16, 2024Aug 19, 2024 Form 4 ↗
Culley Brian MPresident and CEO · Director Purchase +10.0K $1.05 $11K154.8Kdirect May 24, 2024May 28, 2024 Form 4 ↗
BAILEY DON MDirector Purchase +96.2K $1.04 $100K158.8Kindirect Feb 8, 2024Feb 8, 2024 Form 4 ↗
BROADWOOD PARTNERS, L.P.Director · 10% owner Purchase +0 $0.00 $041.7Mindirect Feb 6, 2024Feb 8, 2024 Form 4 ↗
BROADWOOD PARTNERS, L.P.Director · 10% owner Purchase +6.7M $1.04 $7.0M41.7Mdirect Feb 6, 2024Feb 8, 2024 Form 4 ↗
Jayasuriya AnulaDirector Purchase +10.0K $1.09 $11K10.0Kdirect Dec 29, 2023Jan 2, 2024 Form 4 ↗
Culley Brian MPresident and CEO · Director Purchase +6,400 $1.53 $10K97.8Kdirect Mar 31, 2022Apr 4, 2022 Form 4 ↗
Amin DiptiDirector Purchase +35.0K $1.63 $57K35.0Kdirect Mar 28, 2022Mar 29, 2022 Form 4 ↗
Culley Brian MPresident and CEO · Director Purchase +5,250 $1.38 $7K81.3Kdirect Mar 25, 2022Mar 28, 2022 Form 4 ↗
BRADSHER NEAL CDirector · 10% owner Purchase +0 $0.00 $034.9Mindirect Mar 25, 2022Mar 25, 2022 Form 4 ↗
BRADSHER NEAL CDirector · 10% owner Purchase +470.0K $1.44 $677K34.9Mdirect Mar 25, 2022Mar 25, 2022 Form 4 ↗
Mulroy Michael H.Director Purchase +7,000 $1.40 $10K258.6Kdirect Mar 24, 2022Mar 25, 2022 Form 4 ↗
BRADSHER NEAL CDirector · 10% owner Purchase +0 $0.00 $034.5Mindirect Mar 24, 2022Mar 25, 2022 Form 4 ↗
BRADSHER NEAL CDirector · 10% owner Purchase +200.0K $1.42 $284K34.5Mdirect Mar 24, 2022Mar 25, 2022 Form 4 ↗
BRADSHER NEAL CDirector · 10% owner Purchase +0 $0.00 $034.3Mindirect Mar 23, 2022Mar 25, 2022 Form 4 ↗
BRADSHER NEAL CDirector · 10% owner Purchase +260.1K $1.37 $356K34.3Mdirect Mar 23, 2022Mar 25, 2022 Form 4 ↗
Hogge Gary S.SVP,Clinical & Medical Affairs Sale −28.4K $2.44 $69K0direct Dec 29, 2021Dec 30, 2021 Form 4 ↗
Hogge Gary S.SVP,Clinical & Medical Affairs Sale −9,250 $2.49 $23K28.4Kdirect Dec 29, 2021Dec 30, 2021 Form 4 ↗
Hogge Gary S.SVP,Clinical & Medical Affairs Sale −501.6K $2.45 $1.2M28.4Kdirect Dec 28, 2021Dec 30, 2021 Form 4 ↗
ANDREWS DEBORAH JDirector Sale −19.1K $2.93 $56K15.6Kdirect Jun 29, 2021Jun 30, 2021 Form 4 ↗
Russell Angus C.Director Sale −4,720 $2.97 $14K87.5Kdirect Jun 29, 2021Jun 30, 2021 Form 4 ↗
Culley Brian MPresident and CEO · Director Sale −450.0K $2.87 $1.3M45.7Kdirect Jun 28, 2021Jun 30, 2021 Form 4 ↗
Hernandez AlexandraSr Director Finance/Controller Sale −6,000 $2.23 $13K0direct Mar 30, 2021Apr 1, 2021 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +0 $0.00 $034.0Mindirect Aug 15, 2019Aug 15, 2019 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +13.1K $0.97 $13K34.0Mdirect Aug 15, 2019Aug 15, 2019 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +0 $0.00 $034.0Mindirect Aug 14, 2019Aug 15, 2019 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +1,407 $0.98 $1K34.0Mdirect Aug 14, 2019Aug 15, 2019 Form 4 ↗
Leavitt Chase C.General Counsel/Secretary Purchase +5,000 $1.02 $5K5,000direct Aug 13, 2019Aug 15, 2019 Form 4 ↗
Roberts BrandiCFO & SVP, Finance Purchase +5,000 $1.01 $5K5,000direct Aug 13, 2019Aug 15, 2019 Form 4 ↗
Culley Brian MPresident and CEO · Director Purchase +10.0K $1.01 $10K84.5Kdirect Aug 13, 2019Aug 15, 2019 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +0 $0.00 $034.0Mindirect Aug 13, 2019Aug 15, 2019 Form 4 ↗
BROADWOOD CAPITAL INC10% owner Purchase +10.0K $0.99 $10K34.0Mdirect Aug 13, 2019Aug 15, 2019 Form 4 ↗

Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →